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Abstract
To investigate the phenotypic evolution of West Nile virus (WNV) in California, we competed 
sixteen isolates made during 2007-08 against COAV997-5nt, a genetically marked clone from the 
founding 2003 California isolate COAV997-2003. Using in vivo fitness competitions in House 
Finches (HOFI) and Culex tarsalis mosquitoes, we found that the majority of WNV WN02 and 
SW03 genotype isolates exhibited elevated replicative fitness in both hosts compared to 
COAV997-5nt. Increased replicative capacity in HOFIs was not associated with increased 
mortality, indicating that these isolates had not gained avian virulence. One WN02 isolate from 
Coachella Valley, a region geographically close to the isolation of COAV997, showed neutral 
fitness in HOFIs and reduced fitness in Cx. tarsalis. Two isolates from Kern County and 
Sacramento/Yolo County out-competed COAV997-nt in HOFIs, but were transmitted less 
efficiently by Cx. tarsalis. Competition demonstrated neutral or increased fitness that appeared 
independent of both WN02 and SW03 genotypes.
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Introduction
West Nile virus (WNV; Flavivirus, Flaviviridae) was first detected in California when 
infectious virus was isolated from a Culex tarsalis Coquillett mosquito pool 
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(COAV997-2003)collected in Imperial County in 2003 (Reisen, Lothrop et al., 2004). In 
subsequent years, WNV became endemic, with recurring outbreaks of disease in humans 
and equines throughout the state (Hom, Marcus et al., 2005; Hom, Bonilla et al., 2006). An 
enzootic transmission cycle between passeriform birds and ornithophagic Culex mosquitoes 
was shown to maintain WNV in nature, with transmission peaking during the warm summer 
and fall months. Sequences of WNV isolates made from mosquitoes collected from 
throughout California indicated that all viruses contained the E-V159A mutation defining 
the WN02 genotype (Duggal, Reisen et al., 2015). In addition, some isolates also had the 
NS4A-A85T mutation defining the SW03 clade. Based on phylodynamic studies of time-
stamped genomes, WN02 apparently invaded California once during 2002.3 (time interval 
range 2001.9 – 2002.7) (Duggal, Reisen et al., 2015), agreeing with previous estimates 
(Pybus, Suchard et al., 2012). Subsequently, there were three introductions of the SW03 
clade between 2003.3 and 2006, and by 2008 both genotypes were co-circulating throughout 
California (Duggal, Reisen et al., 2015). Emergence of an additional SW03 clade was 
evident from mutation at the NS4B locus from a WN02 virus from the CA-introduced clade 
(Fig. 1).
What remains unclear is how the establishment of different genotypes of WNV in the varied 
biomes of California and their persistence during winter has altered the replicative 
phenotypes of the genetic variants detected through sequencing studies. The distribution of 
WNV in California encompasses very diverse biomes, including hot and dry desert habitats 
in the southeast, cool maritime locales in the Los Angeles basin and coastal regions, mixed 
agricultural areas in the southern San Joaquin Valley, and comparatively wet conditions in 
the northern Sacramento Valley rice production area. Enzootic transmission cycles in these 
regions differ by vector and host species composition, with Cx. tarsalis being the primary 
vector in rural areas and Culex pipiens quinquefasciatus Say and Culex pipiens intergrades 
predominating in urban habitats in the south and north, respectively (Kothera, Nelms et al., 
2013). American crows (Corvus brachyrhynchos) are important amplification hosts in the 
Los Angeles and Sacramento areas, but not in Coachella Valley and Kern County where they 
are less abundant (http://www.mbr-pwrc.usgs.gov/bbs/ra2013/ra04880.htm).
The current study was originally designed to determine if the phenotype of the invading 
WN02 genotype, as defined by competitive fitness, changed over a five year period as the 
virus dispersed and adapted to different hosts and vectors in California. However, 
subsequent sequencing studies revealed repeated invasions by the SW03 genotype, 
emergence of the SW03 variant from the CA-introduced WN02 genotype, and dispersal by 
both the WN02 and SW03 genotypes from southern to northern California (Duggal et al. 
2015), confounding our adaptive hypothesis and resulting in the current investigation 
describing how different isolates from different biomes varied in competitive fitness 
compared to the founding virus from Imperial Valley. Although the evolution of WNV can 
be tracked by sequencing studies, these documented genetic changes may not necessarily be 
linked directly to infection phenotype, virulence or epidemic potential.
To study changes in the phenotype of WNV, we previously developed an in vivo fitness 
competition model that compared the concurrent competitive replication of two viruses 
within the same host (Worwa, Wheeler et al., 2015). We selected the House Finch 
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(Haemorhous mexicanus [Muller], HOFI) and the mosquito Cx. tarsalis as experimental 
hosts, because they were considered to be moderately susceptible to WNV infection (Reisen, 
Fang et al., 2005) and should therefore best express differences in viral fitness. An infectious 
clone derived from the California founding isolate, COAV997-2003, was genetically marked 
with five synonymous nucleotide substitutions in the envelope gene (COAV997-5nt), and an 
allele-specific qRT-PCR assay was developed to quantify viral RNA from samples 
containing both wildtype WNV and COAV997-5nt viruses (Worwa, Andradeet al., 2014). 
COAV997-5nt retained equal fitness compared to COAV997 in both in vitro and in vivo 
evaluations in single and dual infections (Worwa, Andrade et al., 2014; Worwa, Wheeler et 
al.,2015). To determine whether WNV had changed phenotypically over time and space, we 
characterized the fitness of sixteen WNV isolates made during 2007 and 2008 by competing 
them against COAV997-5nt in HOFIs and Cx. tarsalis.
Results and Discussion
Genetic characterization of viral strains
Complete genome sequences of all 16 WNV isolates were determined and the consensus 
sequences compared to the COAV997-2003 strain (Supplemental Table 1). All viruses 
contained the NS3-249 mutation imparting elevated virulence in American crows (Brault, 
Huang et al., 2007) and the E-V159A mutation defining the WN02 genotype (Davis, Ebel et 
al., 2005). The NS4A-F92L mutation associated with the temperature-sensitive phenotype of 
COAV997 (Andrade, Maharaj et al., 2011) was not retained in any of the wildtype isolates, 
which was expected because elevated temperatures such as those recorded in febrile 
American crows have been shown in vitro to preclude replication (Andrade, Maharaj et al., 
2011). Based on the presence of the NS4A-A85T mutation that defines the SW03 genotype 
(McMullen, May et al., 2011), ten of the viruses were considered to be the SW03 genotype 
and six were the WN02 genotype (Table 1). Therefore, ten fitness evaluations compared the 
founding WN02 strain in California to the SW03 strain, and six evaluations compared the 
founding WN02 strain to WN02 viruses collected five years after adapting and dispersing in 
California. The phylogenetic relatedness of these 16 isolates based on sequence data is 
shown in Fig. 1 and discussed within a broader genetic context in Duggal, Reisen et al. 
(2015).
The place and date of virus isolation, the mosquito host, the Ct value [index of RNA copies], 
titer at first passage on Vero cell culture, and the RNA copy to plaque forming unit ratio are 
shown in Table 1. The RNAcopy-to-PFU ratio of each virus stock varied markedly, ranging 
between 0.08 and 0.67 (Table 1). In contrast, the RNA copyto-PFU ratio for COAV997-5nt 
was 0.004, and therefore considerably greater indicating the generation of a greaternumber 
of non-infectious RNA copies for this virus. To correct for this bias in RNA copy generation, 
we determined the ratio of RNA copies from COAV997-5nt and wildtype viruses for all 
subsequent bird inocula and mosquito blood meals (Tables 3 and 4) and adjusted the RNA 
copy numbers from the competition samples accordingly, as describedpreviously (Worwa, 
Wheeler et al., 2015).
Worwa et al. Page 3
Virology. Author manuscript; available in PMC 2019 January 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Recent WNV isolates demonstrate greater competitive fitness in HOFIs
The peak and duration of elevated viremia is a biologically relevant metric for viral fitness, 
because viral titers in infected avian hosts must reach or exceed levels that effectively infect 
mosquitoes for transmission to continue (Komar, Langevin et al., 2003; Reisen, Fang et al., 
2005). HOFI were dual-inoculated with a mixture of a wildtype WNV isolate and 
COAV997-nt marked virus. The RNA copy numbers for wildtype and COAV997-5nt viruses 
in HOFI sera collected between 1 and 7 days post infection (dpi) are presented in Figure 2. 
Additionally, the relative abundance of viral RNA from wildtype or COAV997-5nt viruses 
was presented as a percentage of the total virus population present on any given day (Fig. 2). 
On 1 dpi there were no statistically significant differences in RNA copies between 
COAV997-5nt and any of the wildtype isolates. Between 2 and 7 dpi all WNV WN02 and 
SW03 isolates from GRLA, KERN and SAYO demonstrated either neutral or significantly 
higher competitive fitness in HOFIs compared to COAV997-5nt. Viremias of all wildtype 
isolates peaked on 3 dpi, except for WN02 isolate COAV-08-1722 that peaked on 4 dpi, 
concurrent with COAV997-5nt. At peak viremia, higher RNA copy numbers from wildtype 
isolates were present compared to COAV997-5nt, except for COAV-08-1091 which showed 
equal replication efficiency on 3 dpi (Fig.2, Table 2). Although isolates COAV-07-1573, 
COAV-08-1333 and SAYO-08-6803 replicated significantly better in HOFIs than 
COAV997-5nt early in the infection, their RNA copy numbers decreased on 6 dpi to non-
significantly different levels compared to COAV997-5nt (Table 2). Interestingly, isolate 
COAV-08-1091 of the SW03 clade exhibited neutral replication to COAV997-5nt during 2, 3 
and 4 dpi, but ultimately “lost” the competition to COAV997-5nt on 5, 6 and 7 dpi (Fig. 2). 
By the end of the competitions on 7 dpi, RNA from COAV997-5nt was not detectable in 
many of the birds that previously showed better replication of wildtype isolates. However, 
although replicating equally on 3 dpi, isolate COAV-08-1091 disappeared by 6 dpi with only 
COAV997-5nt RNA being detected on 7 dpi. Similarly, isolate COAV-08-1333 demonstrated 
equal replication to COAV997-5nt by the end of the competition (Fig 2). This may indicate 
some degree of attenuation of these isolates compared to contemporary strains that 
outcompeted COAV997-5nt. These data generally agreed with host competence studies in 
house sparrows (HOSP; Passer domesticus) that showed recent isolates of WNV exhibited 
increased viremia and host competence (Duggal, Bosco-Lauth et al., 2014).
Mortality in birds may be associated with WNV virulence due to increased viral replication 
(Brault, Langevin et al., 2004; Langevin, Brault et al., 2005) and thus impact viral fitness. 
Previously, we determined that the mortality rate for COAV997-5nt in feral HOFIs from 
California was less than 17% in single and dual infections (Worwa, Wheeler et al., 2015). 
Most wildtype WNV isolates in the current study did not cause mortality in HOFIs, similar 
to COAV997-5nt (Fig. 3). Therefore, although these WNV isolates demonstrated increased 
replicative fitness in HOFIs compared to COAV997-5nt in dual infections (Fig. 2), virulence 
as indicated by increased mortality did not appear to be concurrently elevated. These results 
differed somewhat from recent studies using the HOSP as the experimental host (Duggal, 
Bosco-Lauth et al., 2014), where recent WNV strains showed high peak viremia and 
mortality. Interestingly, competition with isolate WN02 GRLA-08-277 resulted in a 
markedly elevated mortality rate of 67%, with one bird from this group developing overt 
neurological signs of WNV disease on 11 dpi. When analyzing this HOFI's brain 
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homogenate by qRT-PCR, we found over 6 log10 of RNA copies of isolate GRLA-08-277 
and no viral RNA for COAV997-5nt. The GRLA-08-277 isolate was collected in the spring 
of 2008 in Los Angeles prior to a major WNV outbreak of human disease later that year 
(Kwan, Kluh et al., 2010), possibly indicating that isolates from outbreaks might be 
associated with elevated avian virulence in addition to increased replicative fitness.
Neutral or elevated replication of recent isolates in Culex tarsalis
To be transmitted effectively by mosquitoes, viruses must infect and replicate in multiple 
tissues and then be expectorated during the imbibing of subsequent blood meals (Hardy, 
Houk et al., 1983). Culex tarsalis were fed a bloodmeal containing a mixture of a recent 
wildtype WNV isolate and the COAV997-5nt marked virus. RNA copy numbers in Cx. 
tarsalis bodies were assessed at 14 dpi using qRT-PCR, the amount of RNA from wildtype 
isolates and COAV997-5nt statistically compared (Fig. 4), and the ‘competition winner’ 
listed in Table 2. Isolate COAV-08-1091 of the SW03 clade was the only isolate that infected 
and replicated less efficiently compared to COAV997-5nt. Isolates GRLA-07-5894, 
GRLA-08-5546, GRLA-08-6006, KERN-08-360, SAYO-07-6588 and SAYO-08-6803 from 
both WN02 and SW03 lineages replicated to equal levels compared to COAV997-5nt, and 
therefore showed neutral fitness (Fig. 4, Table 2). All other wildtype isolates consisting of 
both WN02 and SW03 lineages infected and replicated to significantly greater levels of 
wildtype RNA than COAV997-5nt. There were not sufficient mosquitoes infected with 
isolate WN02 SAYO-08-2604 to allow statistical comparison.
To assess transmission rates following infection competition in Cx. tarsalis, viral RNA was 
measured in the expectorants of mosquitoes that had detectable WNV RNA present in their 
bodies at 14 dpi (Fig. 5). Both wildtype and COAV997-5nt viruses were found in mosquito 
bodies and expectorants from each group, suggesting that, unlike infections in HOFI, a 
complete displacement of one of the viruses had not occurred during infection and 
subsequent dissemination from the midgut to the salivary glands (Fig. 5). Therefore, to 
determine relative fitness based on infection, the ratio between RNA from wildtype isolates 
and COAV997-5nt in bodies and expectorants (Table 2) was compared to the ratio of RNA 
in the blood meals used to infect Cx. tarsalis (Table 4). With a ratio of 1, the isolate SW03 
KERN-08-360 was neutrally fit compared to COAV997-5nt based on equal numbers of 
bodies containing KERN-08-360 and COAV997-5nt viral RNA. For all other groups, the 
wildtype viruses infected proportionately more mosquitoes, resulting in a ratio greater than 
1. Virus-specific infection rates for wildtype or COAV997-5nt viruses were summarized in 
Fig. 5. Surprisingly, the number of RNA copies found in the mosquito bodies (Fig. 4) did not 
always agree with the infection rate (or proportion of mosquitoes infected) (Fig. 5); e.g., 
isolate COAV-08-1091 replicated to lower RNA levels (Fig. 4), but infected a greater number 
of mosquitoes compared to COAV997-5nt (Fig. 5). Therefore, RNA concentration in the 
mosquito and the frequency of infection among mosquitoes may represent two different 
measures of fitness in the vector that should be evaluated separately. We observed lower 
infection frequencies for mosquitoes infected with SAYO 2008 isolates, especially isolate 
WN02 SAYO-08-2604. Interestingly, this low infectivity was seen with both wildtype and 
COAV997-5nt viruses.
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Culex tarsalis predominately transmits recent WNV isolates
Viral RNA in mosquito expectorants was quantified by qRT-PCR directly from the 
originalmaterial and from Vero cell culture supernatant after one passage (Fig. 5). Passage of 
thetransmitted viruses did not markedly change the ratio of the abundance of these viruses 
comparedto the unpassaged expectorant (Fig. 5), but increased the number of positive 
expectorantsamplesconsiderably as few viral particles were expectorated by many females. 
We again determined the ratio between RNA from wildtype and COAV997-5nt viruses in the 
cell culture supernatant of passaged expectorants to assess competitive fitness among the 
viruses based on transmission (Table 2). Additionally, the percentage of dually and singly 
infected mosquitoes as well as virus-specific transmission rates were summarized in Fig. 6. 
SW03 isolates COAV-08-1091, KERN-08-360 and SAYO-07-6588 presented reduced fitness 
with ratios of 0.61, 0.57 and 0.77, respectively, indicating decreased transmission of these 
viruses compared to WN02 COAV997-5nt. Isolate SW03 GRLA-07-5894 demonstrated 
equal fitness compared to COAV997-5nt, with a ratio of 1 and a transmission rate of 71% for 
both viruses (Fig. 5). In contrast, all other wildtype viruses of both WN02 and SW03 
lineages were transmitted more frequently than COAV997-5nt (Table 2, Fig. 5). Similar to 
Cx. tarsalis body infections, both viruses appeared in the expectorants of each group, yet in 
varying concentrations. Finally, the transmission rate agreed better with RNA levels found in 
mosquito bodies than with the body infection frequency data, likely because viruses with 
high concentrations in the bodies were transmitted more frequently (Table 2).
After analyzing infections and transmissions as a sum of all infected mosquito bodies and 
expectorant samples from each group, we then examined the frequency of singly and dually 
infected mosquitoes (Fig. 6). We identified single and dual infections of bodies in all groups, 
with 288 out of 473 (61%) infected bodies containing both viruses at 14 dpi. In contrast, 
many expectorants tested positive for only one virus, indicating that dissemination or 
salivary gland barriers selected for one of the viruses infecting their bodies (Fig. 6). To 
demonstrate that this observation was not biased by propagation in Vero cells, we showed 
that transmission of a single virus was also more frequent in the original expectorant 
(supplemental Fig. 1).
It was unclear how entry of one virus into the midgut might impact or potentially facilitate 
entry and concurrent replication of a second virus. It is possible that viruses formed 
individual infection foci and may not have actually competed within the same midgut cells. 
In this case, replicative fitness would have been determined by the number of infection foci, 
the amount of virus escaping the midgut and entering the hemocoel, and therefore the 
amount of virus disseminating to the salivary gland. However, although dual infection of the 
mosquito enabled direct competition of viral growth within the vector, it is virus 
transmission that is the biologically relevant outcome measure of fitness. Based on this 
metric, the majority of wildtype isolates showed greater transmission fitness compared to 
COAV997-5nt, indicating enhanced vector competence over time for both WN02 and SW03 
lineage viruses.
Conclusions—Most of the sixteen WNV isolates representing both the WN02 and SW03 
lineages from California showed increased replicative fitness in HOFIs [day 3 viremia: 
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100% and 90%, respectively] and Cx. tarsalis mosquitoes [transmission ratios: 60% and 
83%, respectively] compared to the founding 2003 California isolate COAV997-nt (Table 2). 
However, mosquitoes frequently were infected with and expectorated both strains of virus. 
These data suggest that the the avian host may have provided greater selection pressure than 
the RNAi pathways within the mosquito host that tolerated replication of both viruses.
Virus strains from Coachella Valley adjacent to the Salton Sea and near to Niland in Imperial 
County where COAV997-2003 was isolated showed the most limited changes in fitness. The 
isolate COAV-08-1091 demonstrated an attenuated phenotype in Cx. tarsalis and neutral 
fitness in HOFIs based on peak viremia. The hot and dry climate in Coachella Valley and 
utilization of the same vector and host species in enzootic transmission as the founding virus 
may have limited WNV genetic change compared to other regions in California. In addition, 
several introductions of the WN02 and SW03 genotypes occurred in California during and 
after the time COAV997-2003 was isolated, which also may have contributed to differences 
seen in WNV in these other regions over time (Duggal, Reisen et al., 2015). We did not 
identify phenotypic differences among isolates collected at different time points during the 
WNV transmission season, including fall and spring of successive years, suggesting that 
overwintering did not have an immediate and measurable impact on replicative fitness. What 
remains to be investigated is whether isolates preceding and during outbreaks, such as 
GRLA-08-277, exhibit higher viremias and more virulent phenotypes in birds, similar to 
isolates belonging to the East Coast genotype, or more infectious phenotypes for vectors to 
facilitate explosive amplification to epidemic levels.
Materials and Methods
Ethics
The University of California in Davis is approved for animal experimentation under the 
National Institutes of Health (NIH) assurance number A3433. All animal experimentation 
strictly followed the recommendations of the Guide for the Care and Use of Laboratory 
Animals from the American Veterinary Medical Association (AVMA). House Finches were 
trapped under US Federal Fish and Game permit MB-082812-1 and State Fish and Game 
collecting permit SC-002281. Depredation permits allowed trapping and removal of feral 
House Finches at multiple vineyards near Bakersfield, CA using modified Australian Crow 
traps and no endangered species were caught by us during this process. The Kern Mosquito 
and Vector Control District in Bakersfield provided permission to obtain blood samples from 
chickens for the generation of infectious blood meals approved under IACUC protocol 
15892. No collection permits were necessary to operate dry-ice baited traps for the 
collection of mosquito pools from multiple sites as part of the California Mosquito-Borne 
Encephalitis Virus Surveillance Program. Husbandry and experimental procedures with 
House Finches were approved under the University of California Davis Institutional Care 
and Use Committee (IACUC) protocol number 15895. The animal biosafety level 3 facility 
housing the aviaries and insectary used for the current study was approved under USDA 
permit 47901 and Biological Use Authorization 0872 by the Environmental Health and 
Safety Institutional Biosafety Committee of the University of California, Davis. House 
Finches were observed daily through cage-side inspection by a veterinarian (G. Worwa) and 
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animals showing clinical signs of disease such as shivering, puffy plumage appearance, 
lethargy, disorientation and ataxia were assessed individually. Animals exhibiting any of the 
above signs, or animals expressing visible pain or distress, were humanly euthanized via 
inhalation of carbon dioxide as specified in IACUC protocol number 15895 and accepted by 
the American Veterinary Medical Association (AVMA) Guidelines for Euthanasia of 
Animals.
California study sites and selection of WNV isolates
A total of sixteen mosquito pools were selected from four representative study sites at 
Sacramento County, Kern County, Los Angeles County and the Coachella Valley in 
Riverside County. The mosquito pools were comprised of the most common mosquito vector 
species in each area and had tested positive for WNV RNA by qRT-PCR as part of the 
California mosquito-borne surveillance program during 2007 and 2008 (Brault, Fang et al., 
2015). Although these Culex species feed on different bird species in different areas of 
California, HOFI were consistently among the most frequently utilized hosts (Thiemann, 
Lemenager et al., 2012). Pools from each site were selected based on the time of collection 
to include one from early, mid and late WNV 2007 and early 2008 transmission seasons to 
investigate seasonal variation in fitness, including overwintering as a potential bottleneck. A 
summary of the collection dates, locations and mosquito species for each pool is presented 
in Table 1. Supernatants from the sixteen selected mosquito pool homogenates were 
propagated once in African Green Monkey kidney cells (Vero cells; ATCC no. CCL-81) 
maintained in Dulbecco's Modified Eagle Medium (DMEM; Life Technologies, Gibco, 
Carlsbad, CA) and supplemented with 10% of FBS. The Ct value of the original mosquito 
pool homogenates and viral titers following one passage in Vero cell culture are listed in 
Table1 as well as the range of RNA copy to PFU ratios.
Phylogenetic analyses of California strains used as COAV997 competitors
Previously full-length genomes of WNV isolates collected between 1999 and 2012 were 
sequenced (Duggal, Reisen et al., 2015). The coding regions of all sequences were aligned 
using Clustal Omega (Sievers, Wilm et al., 2011) and edited manually. jModelTest2 was 
used to determine the most appropriate nucleotide substitution model, which was a 
generalized time reversible (GTR) model with a gamma (Γ) distribution of rate variation 
among sites (Darriba, Taboada et al., 2012; Guindon, Dufayard et al., 2010). Phylogenies 
were constructed using the Bayesian MCMC method in BEAST v1.8 (Drummond, Suchard 
et al., 2012) with a GTR + Γ substitution model, a lognormal relaxed molecular clock, and a 
time-aware smoothed GMRF Bayesian Skyride coalescent model (Drummond, Nicholls et 
al., 2002; Minin, Bloomquist et al., 2008). Distances were calculated based on great circle 
distances. Spatial parameters were estimated using relaxed random walks (RRW) and a 
heterogeneous probability distribution of diffusion to allow for variation in dispersal rate, as 
previously determined to be most appropriate for WNV in North America (Pybus, Suchard 
et al., 2012). MCMC chains were run for 200 million states, sampling every 20,000 states. 
Convergence was evaluated using Tracer v1.6. The maximum clade credibility (MCC) tree 
was determined using TreeAnnotator and visualized using FigTree v1.4.2 and SPREAD 
(Bielejec, Rambaut et al., 2011). Computing resources were used from the Cipres Science 
Gateway (Miller, Pfeiffer et al., 2010).
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In vivo fitness competitions in HOFIs
Feral, hatching-year House Finches (HOFI; Haemorhous mexicanus) were captured in Kern 
County CA during late summer of 2011 using grain-baited traps and transferred to a 
mosquito-proof outdoor aviary. All birds were administered 0.2mg/mL of chlortetracycline 
(Fort Dodge, Overland Park, KS) in drinking water for 14 days, and sera collected to screen 
for the presence of antibodies against WNV, SLEV and WEEV using an immunosorbent 
assay (Chiles & Reisen, 1998; Ebel, DuPuis et al., 2002). Seronegative birds then were 
transferred to the ABSL-3 facility at UC Davis and allowed a 14 day acclimation period 
prior to inoculation.
Each of the sixteen WNV isolates was competed against COAV997-5nt in HOFIs by 
inoculating approximately an equal concentration of the two viruses (Worwa, Wheeler et al., 
2015). Briefly, groups of six to seven birds were injected subcutaneously above the right 
Musculus pectoralis with a total of 50 μL of each 1:1 virus mixture at 4.3 log10 PFU/mL 
equaling ca. 500 PFU for each virus. Mean+/-SE WNV titer and number of wildtype and 
COAV997-5nt RNA copies per inoculum were shown in Table 3. Here and for mosquito 
infection, COAV997-5nt RNA copies were adjusted to account for non-infectious RNA 
copies produced during culture. Mock-infected controls were administered 50 μL of DMEM.
Following infection, birds were observed daily for clinical signs of WNV disease until the 
end of the experiment at 14 days post infection (dpi). On the day of inoculation and between 
1 and 7 dpi, a total of 100 μL of blood was collected from each bird from the Vena jugularis 
using a 28-gauge needle and diluted in 500μL of DMEM to achieve an approximate 1:10 
serum dilution. A terminal blood sample was collected from all animals prior to euthanasia. 
Birds surviving acute WNV infection were euthanized upon project completion at 14 dpi. 
Bird inocula and serum samples were stored at -80°C until analysis by plaque assay and 
qRT-PCR for determination of infectious titer and RNA copy numbers, respectively. 
Infectious titers and RNA copy numbers quantified in bird inocula are presented in Table 3.
In vivo fitness competitions in Culex tarsalis mosquitoes
Culex tarsalis mosquitoes from a laboratory-adapted colony established from the Kern 
National Wildlife Refuge in Kern County California during 2002 were used for all fitness 
competitions (Worwa, Wheeler et al., 2015). Uninfected mosquitoes were reared in a BSL-2 
insectary at 22°C, a photoperiod of 16:8 (L:D) hours and offered daily a 10% sucrose 
solution. Prior to blood meal exposure, mosquitoes were transferred to the BSL-3 insectary 
and held at 26°C, 12:12 (L:D) hours and approximately 60% humidity.
For fitness competitions, virus-spiked infectious blood meals were generated for each of the 
sixteen WNV isolates by mixing equal concentrations of each wildtype isolate with 
COAV997-5nt. Groups of female Cx. tarsalis mosquitoes were starved for 24 hours before 
being exposed orally to a blood meal containing ca. 7 log10 PFU/mL of the 1:1 virus 
mixture. This concentration was achieved by a 1:10 dilution of the 1:1 virus mixture at 8 
log10 PFU/mL in heparinized chicken blood and offered to mosquitoes in the dark for 1 hour 
at a blood meal temperature of 37°C using the Hemotek membrane system (Discovery 
Workshops, Accrington, Lancashire, UK). Mock-infected mosquitoes were exposed to blood 
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meals spiked with DMEM. After exposure, mosquitoes were anesthetized using carbon 
dioxide and fully engorged females transferred to a clean container. From each group, five 
fully engorged females were frozen at -80°C immediately after exposure to determine the 
infectious titer and RNA copy numbers for all imbibed blood meals (Table 4).
On 14 dpi, all surviving mosquitoes were anesthetized using triethylamine (Fisher Scientific, 
USA) and expectorants collected from each female by inserting the proboscis into a glass 
capillary filled with a 1:1 solution of 50% FBS and 5% sucrose for 10 minutes (Aitken, 
1977). The expectorants were then transferred into a cryovial containing 250 μL of DMEM 
supplemented with 10% FBS, 100 U/mL penicillin, 0.1 g/mL streptomycin and 1.25 μg/mL 
amphotericin B (Life technologies, Gibco, Carlsbad, CA). After removal of the legs, the 
mosquito bodies were placed individually in cryovials containing two 5mm glass beads each 
and the above DMEM diluent, and samples were stored at -80°C. Infectious titers from five 
fully engorged females collected following blood meal exposure and RNA copy numbers 
quantified in blood meals are presented in Table 4.
Sample processing and analysis
Five fully engorged mosquitoes from each group frozen immediately post-blood meal and 
all mosquito bodies were homogenized for a total of four minutes at 24 Hz using a Tissue 
Lyser (Qiagen, USA) and the homogenate clarified by centrifugation. Expectorants were 
passaged once in Vero cell monolayers for additional amplification of transmitted viruses, 
thereby allowing enhanced determination of the competition outcome. Previously we found 
that few infectious virus particles were present in most mosquito expectorant samples, thus 
making it difficult to identify differences in RNA copy numbers measured by our qRT-PCR. 
However, a single passage of expectorants in Vero cell culture did not alter the initial ratio of 
the competing viruses, but markedly improved the ability to measure them (Worwa, Wheeler 
et al., 2015). To confirm the dose administered to birds and mosquitoes at the beginning of 
the competition, viral titers were determined in bird inocula and five fully engorged 
mosquitoes from immediately after blood ingestion using Vero cell plaque assay (Brault, 
Langevin et al., 2004) and titers expressed as log10 PFU/mL. Nucleic acids were extracted 
from all bird and mosquito samples using the MagMAX magnetic particle processor and 
MagMAX-96 Viral RNA isolation Kit (Applied Biosystems, USA) according to the 
manufacturer's protocol. The RNA copy number for each virus was quantified from mixed 
samples using an allele-specific quantitative RT-PCR. We designed this approach 
specifically to distinguish between COAV997-5nt and wildtype isolates of WNV based on 
the five nucleotide polymorphism previously introduced into COAV997-5nt (Worwa, 
Andrade et al., 2014). Resulting RNA copy numbers were normalized to the respective RNA 
ratios detected in the bird inocula and mosquito blood meals to account for minor 
differences at the start of the competition.
Genomes of all WNV isolates were sequenced using the Sanger technique and amino acid 
changes compared to the founding California strain COAV997 [Supplemental Table 1). Cell 
culture supernatants of all isolates were clarified and viral RNA extracted using Viral RNA 
Mini kit (Qiagen, USA). The viral genome was amplified in 6 overlapping amplicons as 
previously described (Duggal, Reisen et al., 2015) with amplicons sequenced directly. 5′ 
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and 3′ genomic termini (5′ UTR and 3′ UTR) were generated and sequenced by 5′ and 3′ 
RACE amplification (Invitrogen). Primer sequences are available upon request. NCBI 
GenBank accession numbers are presented in Table 1.
GraphPad Prism version 5 and SigmaPlot version 11.0 were used for data plotting and 
statistical analysis. For comparisons between two groups, a Mann-Whitney test was utilized 
and statistical significance set to P<0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Using a novel replicative fitness assay, 16 strains of West Nile virus isolated 
in 2007-2008 were competed in vivo against a genetically marked clone from 
the founding WNV strain isolated in 2003.
• Most recent strains of both the WN02 and SW03 genotypes exhibited elevated 
fitness in both House finch and Culex tarsalis mosquito hosts.
• Viremias in House finches were dominated by a single strain.
• Although Cx. tarsalis frequently were infected by both competing strains, 
only one strain was transmitted successfully.
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Figure 1. Phylogenetic comparison of WNV strains
Phylogenetic relationships among WNV isolates used as competition strains. A MCC 
phylogeny constructed from the open reading frame of 112 WNV isolates is shown. The two 
emergent genotypes of WNV are indicated on the phylogeny by color: WN02 in blue lines 
and SW03 in orange lines. The 16 WN02 and SW03 competing strains are numbered and 
indicated by strain designation (See Table 1 for details).
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Figure 2. RNA copy numbers from fitness competitions in HOFIs
Serum samples from all HOFIs were analyzed by qRT-PCR for the presence of RNA from 
wildtype or COAV997-5nt viruses. The number of RNA copies for each virus is presented as 
the arithmetic mean of all birds per group (Table 3) between1 and 7 dpi (x-axis). Lines 
represent mean viral RNA copy number as log10 RNA copies (left y-axis), and bars show the 
percentage of the viral population (right y-axis) present on each day for wildtype isolates 
(blue color) and COAV997-5nt (red color). Panels show results for isolates from COAV (A), 
GRLA (B), KERN (C) and SAYO (D) study sites.
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Figure 3. HOFI mortality rates
The percent survival (y-axis) is presented over the 7-day course of the fitness competition 
(x-axis) per experimental group for isolates from COAV (A), GRLA (B), KERN (C) and 
SAYO (D).
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Figure 4. RNA copy numbers in Cx. tarsalis bodies
Upon completion of the fitness competitions on 14 dpi, the RNA copy numbers of wildtype 
and COAV997-5nt viruses were determined by qRT-PCR in the bodies of all surviving 
females from each isolate (A-D). Dots represent the number of RNA copies as log10 (y-axis) 
detected in each individual mosquito body positive for wildtype isolates (blue color) and 
COAV997-5nt (red color) and include results from singly and dually infected mosquitoes. 
Bars indicate the means and standard deviation and means were compared using Wilcoxon 
Rank Sum test with statistical significance set to P<0.05.
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Figure 5. Detection of viral RNA in Cx. tarsalis expectorants
Expectorants from mosquitoes whose bodies tested positive for viral RNA (Fig. 4) were 
analyzed by qRT-PCR for the presence of viral RNA in the original diluted expectorant 
(Exp. w/o Vero) and in the supernatant following one passage in Vero cells (Exp. w Vero). 
The height of the bars shows the total number of expectorants (n) that tested positive for 
RNA from either wildtype and/or COAV997-5nt viruses. Colors within the bars indicate the 
number of expectorants that tested positive for wildtype isolates (blue) and COAV997-5nt 
(red) and include data from singly and dually infected mosquitoes. For reference, the 
number of mosquito bodies positive for viral RNA was included for each competition. 
Panels group isolates from COAV (A), GRLA (B), KERN (C) and SAYO (D).
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Figure 6. Infection and transmission rates of singly and dually infected Cx. tarsalis
Total infection rates (green bars) were calculated based on the number of all bodies that 
tested positive by qRT-PCR over all blood fed mosquitoes surviving to 14 dpi (n). Similarly, 
total transmission rates (green bars) were determined based on expectorants with detectable 
viral RNA over all qRT-PCR positive bodies. Additionally, total infection and transmission 
rates were split to reflect single (green dotted bars) and dual (green striped bars) infections. 
Virus-specific infection and transmission rates are shown for wildtype isolates (blue bars) 
and COAV997-5nt (red bars) determined from all qRT-PCR positive bodies and 
expectorants, respectively. Transmission results were derived from expectorants passaged in 
Vero cells.
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